Eleison Pharmaceuticals Inc Contracts & Agreements
19 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (3)
- Human Resources (8)
- Uncategorized (2)
- Consulting Agreement, effective as of August 5, 2022, between Eleison Pharmaceuticals LLC and William Fricker (Filed With SEC on September 19, 2022)
- Form of Common Stock Purchase Warrant issued in the Convertible Term Note Offering (Filed With SEC on September 19, 2022)
- Amended and Restated Investor Rights Agreement, dated as of November 13, 2020 (Filed With SEC on February 23, 2022)
- Form of Underwriting Agreement (Filed With SEC on January 24, 2022)
- Form of 2020 Warrants (Filed With SEC on January 24, 2022)
- Employment Agreement, dated as of February 24, 2012, between Eleison Pharmaceuticals LLC and Edwin Thomas (Filed With SEC on January 24, 2022)
- Engagement Agreement, dated as of August 22, 2021, between Eleison Pharmaceuticals Inc. and Gordian Investments, LLC (Filed With SEC on January 24, 2022)
- Eleison Pharmaceuticals Inc. 2020 Equity Compensation Plan (Filed With SEC on January 24, 2022)
- Amended and Restated Investor Rights Agreement, dated as of November 13, 2020 (Filed With SEC on January 24, 2022)
- Master Client Services Agreement, dated April 16, 2021, between Eleison Pharmaceuticals and BioBridges, LLC (Filed With SEC on January 24, 2022)
- Consulting Agreement, effective as May 4, 2021, between Eleison Pharmaceuticals Inc. and Pat Maguire, M.D., PhD (Filed With SEC on January 24, 2022)
- Consulting Agreement, effective as of January 14, 2016, between Eleison Pharmaceuticals LLC and Keith Darragh (Filed With SEC on January 24, 2022)
- Consulting Agreement, effective as of May 19, 2021, between Eleison Pharmaceuticals Inc. and WSM Consulting Group, LLC (Filed With SEC on January 24, 2022)
- Consulting Agreement, effective as of February 25, 2015, between Eleison Pharmaceuticals LLC and Michael Otto, PhD (Filed With SEC on January 24, 2022)
- Consulting Agreement, effective as of January 16, 2013, between Eleison Pharmaceuticals LLC and Bryan Wood (Filed With SEC on January 24, 2022)
- Services Agreement, dated February 4, 2013 between Eleison Pharmaceuticals LLC and Capital Solutions, Inc (Filed With SEC on January 24, 2022)
- Amendment to the Services Agreement, dated August 5, 2013 between Eleison Pharmaceuticals LLC and Capital Solutions, Inc (Filed With SEC on January 24, 2022)
- Stock Purchase Agreement, dated as of July 4, 2020, between Eleison Pharmaceuticals Inc. and BDI Co., Ltd (Filed With SEC on January 24, 2022)
- Letter Agreement, dated as of November 8, 2020, by and between BDI Co., Ltd. and Eleison Pharmaceuticals, Inc (Filed With SEC on January 24, 2022)
